HopeStage
Back to all studies
CompletedNCT06920238

Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use

Device studyAges 18+United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
LebanonSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: April 13, 2025
Recruitment status
Completed
Enrollment listed in the registry
15
Sponsor
Trustees of Dartmouth College
Sponsor type
University
Study type
Device
Intervention type
Device
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT06920238
Official title
Show the full official title

A Phase I Single-Arm Trial to Test the Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use Disorder (CUD)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Lebanon

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Trustees of Dartmouth College, a university.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies